Insulin-like growth factor-I in liver cirrhosis (Q41695656)

7 October 2017

1 reference

title

Insulin-like growth factor-I in liver cirrhosis (English)

1 reference

7 October 2017

Blomsma MC

1

1 reference

7 October 2017

de Knegt RJ

series ordinal

2

1 reference

7 October 2017

Dullaart RP

series ordinal

3

1 reference

7 October 2017

Jansen PL

series ordinal

4

1 reference

7 October 2017

1 December 1997

1 reference

7 October 2017

Journal of Hepatology

1 reference

7 October 2017

27

1 reference

7 October 2017

6

1 reference

7 October 2017

1133-1138

1 reference

Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients.

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Disordered Energy and Protein Metabolism in Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

The insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Normal control of growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Expression of insulin-like growth factor II, α-fetoprotein and hepatitis B virus transcripts in human primary liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

The hormonal control of protein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

IGF-I alters energy expenditure and protein metabolism during parenteral feeding in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Growth hormone and insulinlike growth factor I enhance host defense in a murine sepsis model.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Spontaneous bacterial peritonitis is associated with high levels of interleukin-6 and its secondary mediators in ascitic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

The regulation of L-proline transport by insulin-like growth factor-I in human osteoblast-like SaOS-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Insulin-like growth factor I as a predictor of cortical bone mass in a long-term study of ovariectomized and estrogen-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Comparative study of the lipolytic potencies of pituitary-derived and biosynthetic human growth hormone in hypopituitary children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Clinical aspects of growth hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Serum growth hormone-binding protein, insulin-like growth factor-I, and growth hormone in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Absence of growth-hormone receptor in hepatocellular carcinoma and cirrhotic liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Decreased serum growth hormone-binding protein in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Glucose metabolism and liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Inter-relations between growth hormone, insulin, insulin-like growth factor-l (IGF-I), IGF-binding protein-1 (IGFBP-1) and sex hormone-binding globulin in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Effects of in-vivo administration of insulin-like growth factor-I on the rate of glucose utilization in the soleus muscle of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980161-4

7 January 2021

10.1016/S0168-8278(97)80161-4

Identifiers

DOI

1 reference

7 October 2017

1 reference